Gan & Lee Pharmaceuticals. (SHA:603087)
China
· Delayed Price · Currency is CNY 59.81
-0.42 (-0.70%)
Apr 29, 2026, 3:00 PM CST
SHA:603087 Revenue
Gan & Lee Pharmaceuticals. had revenue of 878.11M CNY in the quarter ending March 31, 2026, a decrease of -10.84%. This brings the company's revenue in the last twelve months to 3.95B, up 13.70% year-over-year. In the year 2025, Gan & Lee Pharmaceuticals. had annual revenue of 4.05B with 33.06% growth.
Revenue (ttm)
3.95B
Revenue Growth
+13.70%
P/S Ratio
9.09
Revenue / Employee
752.22K
Employees
5,245
Market Cap
35.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.05B | 1.01B | 33.06% |
| Dec 31, 2024 | 3.05B | 437.31M | 16.77% |
| Dec 31, 2023 | 2.61B | 895.77M | 52.31% |
| Dec 31, 2022 | 1.71B | -1.90B | -52.60% |
| Dec 31, 2021 | 3.61B | 250.16M | 7.44% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Imeik Technology Development | 2.42B |
| Intco Medical Technology | 10.32B |
| Andon Health | 1.57B |
| iRay Group | 2.46B |
| Zhende Medical | 4.34B |
| Winner Medical | 11.02B |
| Shenyang Xingqi Pharmaceutical | 2.62B |
| Micro-Tech (Nanjing) Co.,Ltd | 3.34B |